Literature DB >> 21540994

Swine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis?

Naoyoshi Maeda1, Toshimitsu Uede.   

Abstract

Influenza viruses are common respiratory pathogens in humans and can cause serious infection that leads to the development of pneumonia. Due to their host-range diversity, genetic and antigenic diversity, and potential to reassort genetically in vivo, influenza A viruses are continual sources of novel influenza strains that lead to the emergence of periodic epidemics and outbreaks in humans. Thus, newly emerging viral diseases are always major threats to public health. In March 2009, a novel influenza virus suddenly emerged and caused a worldwide pandemic. The novel pandemic influenza virus was genetically and antigenically distinct from previous seasonal human influenza A/H1N1 viruses; it was identified to have originated from pigs, and further genetic analysis revealed it as a subtype of A/H1N1, thus later called a swine-origin influenza virus A/H1N1. Since the novel virus emerged, epidemiological surveys and research on experimental animal models have been conducted, and characteristics of the novel influenza virus have been determined but the exact mechanisms of pulmonary pathogenesis remain to be elucidated. In this editorial, we summarize and discuss the recent pandemic caused by the novel swine-origin influenza virus A/H1N1 with a focus on the mechanism of pathogenesis to obtain an insight into potential therapeutic strategies.

Entities:  

Keywords:  Acute lung injury; Influenza virus A/H1N1pdm; Pandemic; Swine-origin influenza virus

Year:  2010        PMID: 21540994      PMCID: PMC3083955          DOI: 10.4331/wjbc.v1.i5.85

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  92 in total

Review 1.  Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.

Authors:  Jeannette Guarner; Reynaldo Falcón-Escobedo
Journal:  Arch Med Res       Date:  2010-01-06       Impact factor: 2.235

2.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

3.  Estimating influenza-associated deaths in the United States.

Authors:  William W Thompson; Matthew R Moore; Eric Weintraub; Po-Yung Cheng; Xiaoping Jin; Carolyn B Bridges; Joseph S Bresee; David K Shay
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

4.  Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-03-05

5.  Immunopotentiating activity of nigerooligosaccharides for the T helper 1-like immune response in mice.

Authors:  S Murosaki; K Muroyama; Y Yamamoto; H Kusaka; T Liu; Y Yoshikai
Journal:  Biosci Biotechnol Biochem       Date:  1999-02       Impact factor: 2.043

6.  Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice.

Authors:  S Murosaki; K Muroyama; Y Yamamoto; Y Yoshikai
Journal:  Cancer Immunol Immunother       Date:  2000-06       Impact factor: 6.968

Review 7.  The evolution of epidemic influenza.

Authors:  Martha I Nelson; Edward C Holmes
Journal:  Nat Rev Genet       Date:  2007-01-30       Impact factor: 53.242

Review 8.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

9.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

Review 10.  The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages.

Authors:  J Robert Coleman
Journal:  Virol J       Date:  2007-01-15       Impact factor: 4.099

View more
  4 in total

1.  Toonaciliatin K attenuates the lung injury induced by lung infection of H1N1 influenza virus by regulating the NF-κB/MyD88/TLR-7 pathway in mice.

Authors:  Xiankun Zeng; Xiaofan Zhang; Dongsheng Wei
Journal:  Arch Med Sci       Date:  2019-11-11       Impact factor: 3.318

2.  Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter.

Authors:  Lourdes Arriaga-Pizano; Eduardo Ferat-Osorio; Gabriela Rodríguez-Abrego; Ismael Mancilla-Herrera; Esteban Domínguez-Cerezo; Nuriban Valero-Pacheco; Marisol Pérez-Toledo; Fernando Lozano-Patiño; Fernando Laredo-Sánchez; José Malagón-Rangel; Haiko Nellen-Hummel; César González-Bonilla; Gabriel Arteaga-Troncoso; Arturo Cérbulo-Vázquez; Rodolfo Pastelin-Palacios; Paul Klenerman; Armando Isibasi; Constantino López-Macías
Journal:  Arch Med Res       Date:  2015-12-13       Impact factor: 2.235

3.  Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus.

Authors:  Maki Kiso; Ryo Takano; Saori Sakabe; Hiroaki Katsura; Kyoko Shinya; Ryuta Uraki; Shinji Watanabe; Hiroshi Saito; Masamichi Toba; Noriyuki Kohda; Yoshihiro Kawaoka
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 4.  Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic.

Authors:  Carolyn M Hendrickson; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2013-08-11       Impact factor: 3.119

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.